Global Perspectives
Global Perspectives Podcast: are we in a sweet spot for credit investing?
A far reaching fixed income discussion on credit market resilience, liquidity versus solvency risks, recovery prospects and the dilemma for central banks in 2021.
Listen now
Global Perspectives Podcast: Fixed Income – Avoiding the BEACH
Adam Hetts talks to Nick Maroutsos and Jason England, portfolio managers on the Absolute Return Income strategies.
Listen now
Global Perspectives Podcast: Making sense of the US election
Which way do markets turn following the US election? Recorded on November 5 as votes continued to come through, our panel of investment professionals gave their views on what the result could mean for investors.
Listen now
Global Perspectives Podcast – Technology: Valuations, Tech Wars, Regulation and Sustainability
In this episode, Adam Hetts talks to Alison Porter and Richard Clode from the Global Technology Leaders Team. The focus is on the main topics impacting the tech sector today, including the acceleration in tech trends, rising valuations, the US-China tech war, regulation, the US presidential election, as well as their approach to ESG factors and how they manage concentration risk in portfolios.
Listen now
Global Perspectives Podcast: Demystifying Sustainable Investing
In this episode, Global Sustainable Equity portfolio managers Hamish Chamberlayne and Aaron Scully join Adam Hetts to decode sustainability and discuss their approach to sustainable investing.
Listen now
Global Perspectives Podcast: Strategic Fixed Income Thinking
In the first in the series, Adam Hetts talks to Co-Heads of Strategic Fixed Income Jenna Barnard and John Pattullo. In a candid conversation, the trio cover global credit, inflationary threats, the impact of COVID, fool’s yield and false summits, among other topics.
Listen nowUnderstanding the science and investment implications of COVID-19
Podcast: Understanding the science and investment implications of COVID-19 (part 7)
In our ongoing series on COVID-19, Portfolio Manager and Research Analyst Dan Lyons and Director of Research Matt Peron discuss the current state of the pandemic and what investors should consider as the economy tries to return to “normal.”
Listen now
Podcast: Understanding the science and investment implications of COVID-19 (part 6)
In this latest installment of our series exploring the scientific and investment implications of COVID-19, Portfolio Manager Andy Acker and Biotech Analyst Agustin Mohedas discuss lessons learned as economies reopen, the virus’s fatality rate and the latest news in vaccine development.
Listen now
Podcast: Understanding the science and investment implications of COVID-19 (part 5)
In the fifth installment of a series on the scientific and investment implications of COVID-19, Biotech Analyst, Agustin Mohedas, discusses how efforts to develop treatments and vaccines have accelerated innovation in healthcare.
Listen now
Podcast: Understanding the science and investment implications of COVID-19 (part 4)
In this fourth installment of a series on the scientific and investment implications of COVID-19, Portfolio Manager and Research Analyst Dan Lyons explains the latest drug developments, as well as whether the US can meet its aggressive testing goals to reopen the economy.
Listen now
Podcast: Understanding the science and investment implications of COVID-19 (part 3)
In the third installment of a series on the scientific and investment implications of COVID-19, Health Care Analyst Rich Carney focuses on the impact of the virus within the US and explores the related developments.
Listen now
Podcast: Understanding the science and investment implications of COVID-19 (part 2)
In the second installment of our series on the scientific and investment implications of COVID-19, Biotech Analyst Agustin Mohedas provides insights on how biotech and pharmaceutical companies are responding to the crisis, and why continued systematic testing for the virus is crucial to the eventual reopening and recovery of the US economy.
Listen now
Podcast: Understanding the science and investment implications of COVID-19 (part 1)
In the first episode of a series on the scientific and investment implications of the coronavirus pandemic, Global Life Sciences Portfolio Manager Andy Acker and Biotech Analyst Agustin Mohedas discuss recent developments made to curtail the spread of COVID-19 and how they view the timeline for an eventual return to normalcy in the global economy.
Listen nowNavigating Coronavirus Uncertainty:
Perspectives from our investment teams, key considerations for investors and business continuity updates from executive leadership.
Webcasts
Visit our dedicated webcast channel featuring the latest live and on-demand presentations and Q&A sessions from our investment professionals.
Contact your local sales representative
For further information on any of our insights or investment solutions contact your local Janus Henderson sales associate.